SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-051915
Filing Date
2020-09-24
Accepted
2020-09-24 17:16:19
Documents
2
Period of Report
2020-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2174
2 POA DOCUMENT poa.txt EX-24.3_938552 2645
  Complete submission text file 0001209191-20-051915.txt   6232
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O DYNAVAX TECHNOLOGIES CORPORATION 2100 POWELL STREET, SUITE 900 EMERYVILLE CA 94608
Business Address
Paradiso Peter R. (Reporting) CIK: 0001825347 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 201196056